Cancer Drug Fails Test, and the Compa...

Cancer Drug Fails Test, and the Company's Stock Tumbles

There are 1 comment on the New York Times story from Dec 26, 2006, titled Cancer Drug Fails Test, and the Company's Stock Tumbles. In it, New York Times reports that:

Telik, a biotechnology company, said Tuesday that a cancer treatment in the experimental stage failed to improve survival in patients with advanced lung cancer or in patients with ovarian cancer, setting off a ...

Join the discussion below, or Read more at New York Times.

Since: Dec 05

Franklin Park, NJ

#1 Dec 27, 2006
Instead of considering a drug that works only ten percent of the time a failure, it would be better to consider such a drug effective for one in ten tumors and to search for those that it works with. A pre-test to determine the efficacy of drugs in a patient could be the first crucial step in personalizing treatment to the individual.

Exciting results have come from studies of multitargeted, "small molecule" drugs that act on multiple receptors in the cancerous cells. Targeted "small-molecule" therapies ruled at the annual ASCO meeting of oncologists. The trend is away from the monoclonals to the small molecules.

Conventionally, chemotherapy is recommended according to guidelines generated by statistical data. According to the FDA, the response rate of a patient that follows these guidelines is approximately 20%. However, according to the National Cancer Institute, those who benefit substantially from "targeted" drugs make up a fairly smaller proportion of cancer patients. What if you are one of those few?

The new "smart" drugs are a really exciting element of cancer medicine. However, they are not for everyone. But don't throw out the baby with the bath water. All the more reason to "pre-test the tumor."

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Telik Discussions

Title Updated Last By Comments
News Telik's Drug Problem (Jun '07) Jun '07 MHL5723 1
News Telik's US shares dive on drug admission (Dec '06) Dec '06 Dmitriy 1
More from around the web